olmesartan sold brand name benicar among others medication used treat high blood pressure taken versions available combination olmesartanhydrochlorothiazide common side effects include dizziness headaches diarrhea back serious side effects may include kidney problems low blood pressure use pregnancy may harm fetus use breastfeeding angiotensin ii receptor antagonist works blocking effects angiotensin patented came medical use available generic commonly prescribed medication united states million ranking among arbs losartan overall valsartan united states olmesartan indicated treatment hypertension people aged six years age older lower blood olmesartan used treatment hypertension may used alone combination antihypertensive us food drug administration fda determined benefits olmesartan continue outweigh potential risks used treatment people high blood pressure according drug contraindications treatment olmesartan include biliary obstruction another major contraindication pregnancy reports scientific literature reveal fetal malformations pregnant women taking sartanderived incidence adverse effects olmesartan reported similar placebo adverse effect occurred patients treated frequently placebo dizziness vs rarely olmesartan cause severe gastrointestinal issues symptoms include nausea vomiting diarrhea weight loss electrolyte abnormalities common among celiac recent studies suggested form spruelike enteropathy could caused inhibition tgfÎ² polypeptide cytokine maintains intestinal homeostasis however still unclear action never observed studies angiotensin ii receptor antagonists olmesartan patients unilateral bilateral renal artery stenosis increases serum creatinine blood urea nitrogen reported longterm use olmesartan medoxomil patients unilateral bilateral renal artery stenosis similar results may ester prodrug completely rapidly hydrolyzed active acid metabolites process carbon dioxide needed patented came medical use olmesartan sevikar hct combined marketed worldwide daiichi sankyo india abbott healthcare pvt ltd trade name winbp zydus cadila trade name olmy ranbaxy laboratories ltd trade name olvance olsar unichem laboratories canada scheringplough olmetec marketing rights brand names benicar benicar hct azor tribenzor united states transferred daiichi sankyo cosette january several preparations containing olmesartan antihypertensives available teva pharmaceuticals produces formulation containing olmesartan amlodipine benicar hct brand name medication containing olmesartan medoxomil hydrochlorothiazide benitec h another medication containing olmesartan medoxomil hydrochlorothiazide marketed glaxosmithkline india olmesartan demonstrated potential benefits reducing progression atherosclerotic buildup arteries large randomized placebocontrolled active drugcontrolled studies conducted participants hypertension stable angina type diabetes longterm treatment olmesartan shown reduce levels markers vascular effect also observed highcholesterol primate test httpsenwikipediaorgwikiolmesartan